Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

E-ISSN： 2212-3873|11|4|326-333

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.11, Iss.4, 2011-12, pp. : 326-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan Schwahn Uwe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 368-383

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 727-730

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of Usnic Acid and its Derivatives on the Activity of Mammalian Poly(ADP-ribose)polymerase 1 and DNA Polymerase β

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 883-893

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis

By Zingarelli B. O'Connor M. Hake P.W.

European Journal of Pharmacology, Vol. 469, Iss. 1, 2003-05 ,pp. : 183-194

Elsevier

Access to resources Recommend Favorite